Please visit us for our in vitro bioanalysis for POPs/EDCs!
BioDetection Systems BV (BDS) is an SME established in 2001 in Amsterdam, that develops, markets and applies effect/cell-based bio-analysis tools to monitor chemical-, clinical-, veterinary drugs, environmental- and food chain risks. Currently more than 50 cell- and HTPS robotic based bioassays are used to predict a wide range of toxicities, including those for dioxins/dl-PCBs (DR), endocrine disruptors (ER/AR/TR/PR/GR), genotoxicicity (p53), obesity (PPAR) and oxidative stress (Nrf2 CALUX®). We are offering training and ISO 17025 accredited service analysis for you!
Copyright 2014, a2z, Inc. All rights reserved.